2048 Ventures — 2024 Investments
5 investments dated 2024 · listed companies and verified rows first · show all
Aclid provides an automation platform for biosecurity and biosafety compliance, offering real-time screening that generates threat assessments and risk profiles for genes, libraries, pools, viral vectors, and plasmids.
BiotechCybersecurityDeep TechSaaSNew York, US
Kevin Flyangolts(Executive Officer, Director, Promoter)in
Board seatAlex Iskold· per SEC Form D
Co-investorsCoalition OperatorsIA Ventures
Adaptis provides a software platform that analyzes building portfolios to baseline assets, cluster similar buildings, and flag energy, cost, and carbon inefficiencies.
Climate TechPropTechSaaSNew York, US
Sheida Shahi(Executive Officer, Director, Promoter)Aida Mollaei(Executive Officer, Director, Promoter)
BoardHeather Widman(Director)
Co-investorsBuilding Ventures
Frate provides an AI-powered, exchange-first returns portal for Shopify brands, automating the returns process while offering fraud detection, smart routing, and recommerce options.
AI & Machine LearningLogistics & Supply ChainRetail TechAustin, US
Jake GoodmanBailey Newton(Executive Officer, Director)
BoardYenn Lei(Director)Ryan Broshar(Director)
Co-investorsBetter Ventures Central LlcMatchstick VenturesBetter VenturesWhitecap Venture Partners
Impacked is a B2B online marketplace for sourcing primary packaging such as bottles, jars, tubes and closures.
New York, US
NATASHA TRUEMAN(Executive Officer, Director)LISA-MARIE ASSENZA(Executive Officer, Director)Lisa-Marie Assenza(Founder)inDAVID WAXMAN(Director)
Co-investorsFirst Row Partners
Neobe Therapeutics is developing a synthetic biology platform to engineer programmable live biotherapeutic products—microbial "trojan horses"—that disrupt the microenvironment of solid tumours.
BiotechDeep TechHealthtech
Co-investorsDeep Science Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.